The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookiesbefore using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

Best borrowers: High regard for high yield

High-yield corporate issuers have faced some challenges over the past 12 months but their popularity has not been in doubt. A recent market investor survey published by Fitch Ratings found that high yield is now the most favoured sector among European fixed-income investors, overtaking even non-financial corporates. According to JPMorgan, there has been a provisional inflow of €1.76 billion (6.9% of assets under management) to high-yield funds in Europe for the year to April.

Certainly Henner Bottcher, group treasurer at HeidelbergCement, which tops Euromoney’s high-yield borrower poll this year, moving from fourth place in 2011, has no doubt that investor appetite for his firm is robust despite the market turmoil. "We have said that we want to regain investment-grade status and we allocate the majority of our free cashflow to delivering. Investors know that we stick to our promises. So they are always there for us," he tells Euromoney.

HeidelbergCement and Fresenius Medical Care, which is ranked second in the survey this year after coming eighth last year, are, however, perhaps the only two regular issuers in European high yield that can be confident of market access despite the macro environment.

The rest of the market has endured a rocky 12 months characterized by sporadic windows of availability. "We came to the market in September and paid 9 5/8% and in March we paid 4% – that is a 5% difference in six months. This is not only explained by the difference in terms of the bonds – there have been huge changes to market conditions," says Bottcher.

Fresenius Medical Care reopened the market in September after the turmoil over the summer with a dual-currency trade in €400 million and $400 million tranches.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.


Unlimited access to and

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually


Unlimited access to and, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors


Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree